GSK plc

Open: 34.84 Close: 34.47 Change: -0.37

How to get information about GSK plc Company Inc without reading the whole internet.

The game is changing. There is a new strategy to evaluate GSK plc fundamental value, possible risks and most salient advantages. Investors have traditionally relied in reading large amounts of text to evaluate the fundamental value of a stock or company. However, the development of Artificial Intelligence (AI) tools is modifying the way investments are evaluated in markets. Today, machine learning, natural language processing and bigdata allow making this process automatic, reducing large amounts of text to the elements that have a higher activation in a neural network. We programmed an artificial intelligence that reads the whole internet and the uses natural language processing and vectorizers to summarize the information. Usually, the AI reads several hundred pages and summarize it to a short document. This document presents our results. We found that the most common words in the internet about GSK plc are: GSK, company, global, get, investor, biopharma, purpose, …

Concept Map

Semantic Network

Stock Summary

GSK plc engages in the research, development and manufacture of vaccines and specialty medicines. It operates through four segments: Pharmaceuticals, Pharmaceuticals R&D, Vaccines, and Consumer Healthcare. The company was formerly known as Gl.

Today's Summary

GSK PLC shares inched up 0.50% to £13.72 Thursday, on what proved to be an all-around positive trading session for the stock market. GSK presented data to the US FDA on August 17, 2023. The consensus rating for GSK is a “Hold” with an average target price set at $1,527.50.

Today's News

GSK cautions investors that any forward-looking statements or projections made by GSK are subject to risks and uncertainties. GSK is a global biopharma company with a purpose to unite science, technology and talent to get ahead of disease together. GSK PLC shares inched up 0.50% to £13.72 Thursday, on what proved to be an all-around positive trading session for the stock market. FTSE 100 Index UKX, +0.18% rising 0.18%, GSK closed £2.37 below its 52-week high (£16.09), which the company achieved in December. AREXVY cost will be covered by most Medicare and commercial insurance plans in the U.S. GSK presented data to the US FDA on August 17, 2023. The GSK RSVPreF3 RSV vaccine has been involved in over ten clinical studies. GSK plc has a 1 year low of $28.47 and a 1-year high of $39.74. The company recently disclosed a quarterly dividend, which will be paid on Thursday, October 12th. GSK had a net margin of 50.26% and a return on equity. GSK is a global biopharma company with a special purpose – to unite science, technology and talent to get ahead of disease together. Were on track to separate and create two new companies in 2022. GSK Bangladesh – a subsidiary of the British pharmaceutical giant GlaxoSmithKline plc – got listed on the Dhaka Stock Exchange in 1976. On December 3, 2018, Unilever NV declared that it would buy GSK shares. GSK PLC has on average historically risen by 13% based on the past 46 years of stock performance. GSK has risen higher in 28 of those 46 years over the subsequent 52-week period, corresponding to a historical accuracy of 60%. GlaxoSmithKline (GSK) has captured the attention of investors and analysts alike due to recent changes in positions by larger investors and significant developments in its financial performance. The consensus rating for GSK is a “Hold” with an average target price set at $1,527.50. GSK plc has fallen 3.16% over the past month, closing at $35.87 on July 26. GSK has an average analyst recommendation of Sell. GSK is set to release earnings on 2023-10-24. Position will have direct reports in multiple countries. Responsibilities and Accountabilities Accountable to GRL (if not the GRL) and/or Global Regulatory TA Head. GSK is a global biopharma company with a special purpose - to unite science, technology and talent to get ahead of disease together. We want GSK to be a workplace where everyone can feel a sense of belonging. GSK is looking for Manufacturing Science and Technology (MSAT) Downstream Lab Scientist in Rockville, MD to join our team. Glaxosmithkline has an opening for a Regulatory Systems Lead in Rockville, MD. Responsible for regulatory submission preparation & review of global submissions, variations/supplements for products produced by the Biopharm site. Berenberg Bank set a target price of 1,730 GBX for the company, which when compared to the GSK plc share price at opening today (22/08/2023) indicates a potential upside of 28.2%.

Stock Profile

"GSK plc, together with its subsidiaries, engages in the research, development and manufacture of vaccines and specialty medicines to prevent and treat disease in the United Kingdom, the United States, and internationally. It operates through four segments: Pharmaceuticals, Pharmaceuticals R&D, Vaccines, and Consumer Healthcare. The company offers pharmaceutical products comprising medicines in the therapeutic areas, such as infectious disease, HIV, immunology and respiratory, and oncology. The company was formerly known as GlaxoSmithKline plc and changed its name to GSK plc in May 2022. GSK plc was founded in 1715 and is based in Brentford, the United Kingdom."

Keywords

Are looking for the most relevant information about GSK plc? Investor spend a lot of time searching for information to make investment decisions in GSK plc. This task is often burdensome and consumes huge amounts of free time. It also leads to mistakes due to fatigue and bounded rationality. As a solution, we programmed an artificial intelligence that reads the whole internet and the uses natural language processing and vectorizers to summarize the information. Usually, the AI reads several hundred pages and summarize it to a short document. This document presents our results. We found that the most common words in the internet about GSK plc are: GSK, company, global, get, investor, biopharma, purpose, and the most common words in the summary are: gsk, stock, plc, best, market, company, news, . One of the sentences in the summary was: The consensus rating for GSK is a “Hold” with an average target price set at $1,527.50.. Other searches related to this term that the AI found were: stockmarketlive, livestock, stockmarketforbeginners, thestockmarket, stockmarkettoday, stockmarkettrading, stockmarketstocks, todaystockmarket, thestockmarket, marketnews, stockmarketnews, whatisstockmarket, usstockmarket, stockmarketopen. #gsk #stock #plc #best #market #company #news.